5a

General Information


DRACP ID  DRACP04954

Peptide Name   5a

Sequence  NOTAVAILABLE

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C45H75N11O13

Absent amino acids  CDFGHKMPQRSWY

Common amino acids  A

Mass  117456

Pl  3.85

Basic residues  0

Acidic residues  1

Hydrophobic residues  7

Net charge  -1

Boman Index  821

Hydrophobicity  116.67

Aliphatic Index  146.67

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23085771

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 15887970

Title  Not available

Doi Not available

Year  Not available

Literature 3

Pubmed ID 11943716

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  4648

CancerPPD ID  4649

CancerPPD ID  4650

CancerPPD ID  4651

CancerPPD ID  4652

CancerPPD ID  4653

CancerPPD ID  4654

CancerPPD ID  4655

CancerPPD ID  4656

CancerPPD ID  4657

CancerPPD ID  4658

CancerPPD ID  4659

CancerPPD ID  4660

CancerPPD ID  4661

CancerPPD ID  4662

CancerPPD ID  4663

CancerPPD ID  4664

CancerPPD ID  4665

CancerPPD ID  4666

CancerPPD ID  4667

CancerPPD ID  4668

CancerPPD ID  4669

CancerPPD ID  4670

CancerPPD ID  4671

DRACP is developed by Dr.Zheng's team.